BRCA2 and familial pancreatic carcinoma: It is presumed that through inactivation of genes involved in maintaining genomic stability (e.g. BRCA2 in models of pancreatic cancer) may promote the stochastic acquisition of genetic and consequent morphologic heterogeneity due to the expected increase in mutation rate.